Abstract Details

Title Efficacy of Alemtuzumab in Treatment-Naive Relapsing-Remitting Multiple Sclerosis: Analysis after Two Years of Study CAMMS223

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 004

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alasdair Coles, MD, PhD (University of Cambridge)	Dr. Coles has nothing to disclose.
Jean Pelletier, MD, PhD (Dpt of Neurology, CHU Timone)	Dr. Pelletier has nothing to disclose.
	No disclosure on file

��ɫ��